The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
The fallout from two fatal crashes of Boeing 737 Max planes has ensnared the manufacturer's most-loyal customer: Southwest Airlines. The carrier has canceled thousands of...Airlinesread more
Brent crude oil jumped the most in history in the previous session after attacks on Saudi's oil industry disrupted the kingdom's production.Marketsread more
In the survey, conducted after the third in the Democratic Party's series of debate, the former vice president draws 31% compared to 25% for the Massachusetts senator. At 14%,...2020 Electionsread more
Stocks rose slightly on Tuesday, but gains were capped as the Federal Reserve kicked off a two-day monetary policy meeting.US Marketsread more
The U.S. Air Force's top general says he hasn't received direction to send additional bombers to the Middle East after what is believed to be Iranian attacks on Saudi Arabian...Defenseread more
Facebook has partnered with Ray-Ban maker Luxottica to develop augmented-reality glasses code-named 'Orion', people familiar with the matter told CNBC.Technologyread more
"I believe the path to 'health care for all' is a path following the lead of the Affordable Care Act," House Speaker Nancy Pelosi tells Jim Cramer.Health and Scienceread more
The pet food and product retailer posted net sales of $1.15 billion, topping estimates of $1.13 billion, according to a survey of analysts by Refinitiv.Retailread more
E-cigarette maker Juul Labs Inc.'s sales have been halted on two websites in China, just days after it launched in the world's biggest tobacco market.Biotech and Pharmaceuticalsread more
The partnership would increase access to Verily's technology by deploying them at Walgreens' pharmacies. A big focus for the companies will be medication adherence, which costs the U.S. health care system some $100 billion to $289 billion a year. Much of this cost is due to increased hospitalizations for patients who get sick when they don't take their medication as prescribed.
Walgreens CEO Stefano Pessina said the company is committed to finding more affordable solutions for patients and that forging the right partnerships is part of that effort.
"The continued rise in chronic diseases today can be costly to patients as well as to our healthcare system," Pessina said in a statement. "Working with Verily, we'll look at how we can best support integrated and value-based care to meet our patients' needs, as well as opportunities to address other chronic conditions over time."
Verily CEO Andrew Conrad said that working with Walgreens provides the health tech company "the opportunity to jointly tackle real-world issues that significantly impact the health of individuals and communities."
Both Walgreens and competitor CVS Health have mentioned lowering health-care costs for consumers as a priority in recent announcements. While competitor CVS Health pursued this goal through its blockbuster acquisition of insurer Aetna, Walgreens has sought to transform itself through a series of partnerships with companies like insurer Humana and diagnostics company LabCorp.
Similarly, it is the latest signal from Verily's parent company Alphabet that it intends to ramp up in the health-care space.
In November, Alphabet's Google hired hospital executive David Feinberg to run its new health division, which is focused on bringing its medical AI research into clinical practice. Verily will not serve under Feinberg, but the two groups are closely aligned. For instance, Verily's head of engineering Linus Upson is currently the interim CEO of that division, but will be replaced by Feinberg when he joins early next year.
The Walgreens collaboration is the unit's first known partnership in the pharmacy space.
The companies said that Onduo, Verily's diabetes company, will work together on a virtual solution for Walgreens employees and their family members. This will be available to those who have been diagnosed with type 2 diabetes. The details on this program are still vague, but the companies said they'd be part of a broader alliance between Verily and Walgreens.
Onduo was created by Verily and pharmaceutical giant Sanofi to roll out what it refers to on its website as a "virtual diabetes clinic." It offers supplies and coaching to people with diabetes to help them manage their condition.
Verily, which was initially known as Google Life Sciences, works closely with health care companies from Johnson & Johnson to Sanofi on joint ventures ranging in scope from next-generation glucose monitors to surgical robots.